Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
11/2001
11/07/2001CN1321162A Solid phase synthesis of thio-oligosaccharides
11/07/2001CN1321148A Aryl-substd. propanolamine derivs., method for their production, medicaments contg. said compounds and their use
11/07/2001CN1320605A Anticancer precursor compound containing anthracycle cytotoxins, its preparing process and its medicine
11/06/2001US6313100 Antibacterial, antiprotozoa agents
11/06/2001US6313099 Use of stereoisomers of calendula gylcosides for the treatment of psoriasis
11/06/2001CA2218724C Metabolites of ginseng saponins by human intestinal bacteria and its preparation for an anticancer
11/06/2001CA2115164C Method for the enzymatic production of .alpha.-glycosides and esters of .alpha.-glycosides, and utilization of the products thereby obtained
11/06/2001CA1341315C Targeted forms of methyltrithio antitumor agents
11/01/2001WO2001080863A1 Bifunctional antibiotics
11/01/2001US20010036927 Complexing
11/01/2001US20010036923 Complex
10/2001
10/31/2001EP0837070B1 Sialic acid derivatives
10/31/2001DE10020275A1 New 2-deoxy-L-ribose and 2-deoxy-D-ribose precursors useful as intermediates for therapeutic nucleic acids and oligonucleotides
10/30/2001US6310227 Reduced calorie cooking and frying oils having improved hydrolytic stability, and process for preparing
10/30/2001US6310200 Comprising carboxylation of an oligosaccharide using a di-tert-alkyl nitroxyl free radical as catalyst and 1,3-dibromo or -chloro-5,5-di-methylhydantoin as oxidizers at a ph of 7-1o; efficiency
10/30/2001US6310091 Fungicidal saponin, CAY-1, and isolation thereof from Capsium species fruit
10/30/2001US6310043 Using compounds which bind to toxins associated with enteric bacterial infection including pentameric toxins, for example slts, such as those from salmonella, camylobacter, e-coli
10/30/2001US6310042 Derivatives of carbohydrates and compositions containing them
10/30/2001CA2227319C Process for hydrogenation of sugars using a shell catalyst
10/25/2001WO2001079268A2 A glycopeptide and preparation thereof
10/25/2001WO2001079267A2 A glycopeptide and preparation thereof
10/25/2001WO2001079243A1 Glycosides of n-acetyl-6-o-[2,2-bis(hydroxymethyl)-3-hydroxypropyl]-d-glucosamine, method for the obtention thereof and their uses in the treatment of brain tumors
10/25/2001WO2001079242A2 Process for preparing lipid ii and derivatives thereof
10/25/2001WO2001021608A3 Novel flavonoids
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001US20010033862 Methods of treating viral infections using antiviral liponucleotides
10/25/2001CA2406953A1 A glycopeptide and preparation thereof
10/25/2001CA2406952A1 Process for preparing lipid ii
10/24/2001EP1147118A1 Substituted alpha-linked disaccharides
10/23/2001US6306915 Oligosaccharides of uronic acid, glucosamine, galactose, and mannose, or one uronic acid; r.sub.2 is an alkyl group, emulsifier of the present invention has marked moisturizing effect, skin roughening preventing effect
10/23/2001US6306893 Taxoid derivatives and process for producing the same
10/23/2001US6306837 Heavy metal chelating agent for oral administration, its synthesis and its uses in medicine and health protection
10/23/2001CA2062788C Improved process for preparing isepamicin
10/23/2001CA2040058C Alpha-mannosidase and fucosidase inhibitors
10/18/2001WO2001077133A1 1-carboxymethyl analogues of lipid a
10/18/2001WO2001077093A1 Estrogen agonist/antagonist metabolites
10/18/2001WO2001076567A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001WO2000056746A3 Improved synthesis of [2.2.1]bicyclo nucleosides
10/18/2001WO2000052018A3 Linkers for synthesis of oligosaccharides on solid supports
10/18/2001US20010029872 Comprising polyol composition containing hydrogenated disaccharide; for admixing with cements and raw materials for mortars
10/18/2001CA2406484A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001CA2405070A1 Estrogen agonist/antagonist metabolites
10/17/2001EP1144430A1 Protecting groups for carbohydrate synthesis
10/17/2001EP1144426A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
10/17/2001EP1144425A1 Derivatives of monosaccharides as cell adhesion inhibitors
10/17/2001EP1144424A2 Derivatized reduced malto-oligosaccharides
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1064291A4 Methods of synthesizing gm3
10/17/2001CN1317938A Compsn. contg. neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-reated diseases
10/16/2001US6303618 Cyclin dependent kinase inhibiting purine derivatives
10/16/2001US6303347 Vaccines
10/16/2001US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group.
10/16/2001CA2065301C Crystalline mixture solid containing maltitol and a process for preparing it
10/11/2001WO2001074835A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001WO2001074834A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001US20010029247 Use of a- alkylglucosides and a-alkylglucoside esters as anti-microbial emulsifying agents
10/11/2001CA2404376A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001CA2404373A1 O-aryl glucoside sglt2 inhibitors and method
10/10/2001EP1142901A1 Polyxyloside derivatives, method of preparation, composition and use as surfactant
10/10/2001EP1142591A1 Gene carriers
10/10/2001EP1140962A2 Novel derivatives from the class of oleandomycin
10/10/2001EP1140961A1 Process for the preparation of ganglioside gm3 by acid hydrolysis of ganglioside inner esters and its use in the pharmaceutical field
10/10/2001EP1140959A1 Inositol-containing hexasaccharides, their synthesis and their uses
10/10/2001EP1140958A1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds
10/10/2001EP1140745A1 Colchinol derivatives as vascular damaging agents
10/10/2001EP1140127A1 Antiprotozoal saponins
10/09/2001CA2161297C Novel diosmetin derivatives; process for preparing the same and pharmaceutical_compositions containing them
10/04/2001WO2001073125A2 High throughput screening array containing porous material
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072762A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/04/2001WO2001072270A1 Hair dyes containing cationic biopolymers
10/04/2001EP1137793A2 Novel nucleic acid transferring agents, compositions containing them and uses
10/04/2001EP1137652A2 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
10/04/2001EP0821691A4 Methods of synthesizing gm2
10/04/2001EP0802920B1 Antifungal fusacandins
10/04/2001EP0674646B1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
10/04/2001EP0529002B1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
10/04/2001CA2403906A1 Pharmaceutical compositions containing oligosaccharides and preparation thereof
10/03/2001CN1315327A Dealcoholizing process for preparing alkylglucoside
10/03/2001CN1315323A Process for extracting glycitin and soybean saponin
10/03/2001CN1315322A Process for extracting glycitin and soybean saponin
10/03/2001CN1315311A Catalyst for preparing alkylglycoside
10/03/2001CN1072229C Maltitol composition and method for preparing same
09/2001
09/27/2001WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
09/27/2001WO2001070209A2 Mono- and disaccharides for the treatment of nitric oxide related disorders
09/27/2001WO2000061541A3 Pharmaceutical compounds
09/27/2001WO2000061537A3 Pharmaceutical compounds
09/27/2001US20010024809 Administering phenylpropanoid derivative as nutrient or therapy; cultured from Ajuga plant under aerobic conditions; free radical scavengers
09/27/2001DE10014340A1 Hair dyeing compositions combining good coloring and conditioning properties, containing cationic biopolymers, alkyl- and/or alkenyl-glycosides and dyes
09/27/2001CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001CA2403553A1 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
09/27/2001CA2403075A1 Mono- and disaccharides for the treatment of nitric oxide related disorders
09/26/2001EP1135400A1 Hygromycin a derivatives as antibacterial agents
09/26/2001EP0528991B1 Detectably labelled marker component comprising a fluorophore moiety , fluorescent probe comprising the marker component and uses thereof.
09/25/2001US6294523 Extended type 1 chain glycosphingolipids as tumor-associated antigens
09/25/2001US6294521 Phosphosugars and phosphosugar-containing compounds having anti-inflammatory activity
09/20/2001WO2001068660A1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
09/20/2001WO2001068659A2 Method for the production of perbenzylated 1-o glycosides
09/20/2001DE10013328A1 Preparation of perbenzylated 1-O-glycosides with a 1-O-functionalized side chain by alkylating a perbenzylated 1-OH-sugar with a reagent containing a protective group to allow large-scale manufacture